Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2025)

Keros Therapeutics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.3 for Q4 2025.

• Quarterly Interest Coverage Ratio rose 99.49% year-over-year to 0.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.69 (down 99.94% YoY) and the FY2025 annual result came in at 0.69, up 149.07% from the prior year.
• Interest Coverage Ratio was 0.3 for Q4 2025 at Keros Therapeutics, up from 2.37 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 52.79 in Q4 2023 and bottomed at 4866.0 in Q4 2021.
• A 5-year average of 250.38 and a median of 0.73 in 2023 frame the typical range for Interest Coverage Ratio.
• Annual changes were most pronounced in 2022 — Interest Coverage Ratio slumped 90921.37% — and 2025, when it surged 9276.05%.
• Keros Therapeutics' Interest Coverage Ratio stood at 4866.0 in 2021, then jumped by 100.94% to 45.72 in 2022, then grew by 15.46% to 52.79 in 2023, then slumped by 210.86% to 58.52 in 2024, then surged by 99.49% to 0.3 in 2025.
• Business Quant data shows KROS's Interest Coverage Ratio at 0.3 in Q4 2025, 2.37 in Q3 2025, and 7.37 in Q2 2025.